Details of the Drug Reposition

General Information of This Drug (ID: DMBLHIS)

Drug Name
Ofranergene obadenovec   DMBLHIS
Synonyms VB-111
Drug Type
Gene therapy

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
1 Phase 3 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Ovarian cancer DISZJHAP 2C73 Phase 3 [1]
------------------------------------------------------------------------------------
1 Phase 2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Glioblastoma of brain DISESTHB 2A00.00 Phase 2 [2]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT03398655) A Study of VB-111 With Paclitaxel vs Paclitaxel for Treatment of Recurrent Platinum-Resistant Ovarian Cancer (OVAL) (OVAL). U.S. National Institutes of Health.
2 ClinicalTrials.gov (NCT04406272) VB-111 in Surgically Accessible Recurrent/Progressive GBM. U.S. National Institutes of Health.